---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-001713"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:15:38.378249+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Processa CEO presents at Biotech Showcase 2024; no financial updates provided

## Summary
- CEO George Ng presentation on Jan 8, 2024 at 1:00 PM PT in San Francisco.
- Presentation titled 'Next Generation Chemotherapy: Improved Treatment for More Patients'.
- Presentation uploaded to investor portal and available on company website.
- No specific financial or pipeline results disclosed in the filing.

## SEC filing metadata
- accession: 0001493152-24-001713
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315224001713/0001493152-24-001713-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315224001713/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-001713
- JSON: https://secwatch.observer/filing/0001493152-24-001713.json
- Plain text: https://secwatch.observer/filing/0001493152-24-001713.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.